Expression of interferon regulatory factor 5 is regulated by the Sp1 transcription factor

Shu,Jin; Wang,Xiao‑Hua; Zhou,Lan‑Bo; Jiang,Chun‑Ming; Yang,Wei‑Xia; Jin,Rui; Wang,Lu‑Lu; Zhou,Guo‑Ping

doi:10.3892/mmr.2016.5565

Expression of interferon regulatory factor 5 is regulated by the Sp1 transcription factor

Authors:
- Jin Shu
- Xiao‑Hua Wang
- Lan‑Bo Zhou
- Chun‑Ming Jiang
- Wei‑Xia Yang
- Rui Jin
- Lu‑Lu Wang
- Guo‑Ping Zhou
View Affiliations

Affiliations: Department of Pediatrics, The First Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China, 2013 Clinical Class 7, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China
Published online on: July 27, 2016 https://doi.org/10.3892/mmr.2016.5565
Pages: 2815-2822

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The transcription factor, interferon regulatory factor 5 (IRF5), is important in the induction of type I interferon, proinflammatory cytokines and chemokines, and is involved in autoimmune diseases and tumourigenesis. However, the mechanisms underlying the transcriptional regulation of wild‑type IRF5 remain to be fully elucidated. The present study was primarily designed to clarify whether specificity protein 1 (Sp1) was involved in the regulation of IRF5. Initially, the IRF5 promoter region was cloned and its promoter activity was examined using Hela and HEK 293 cells. Deletion analyses revealed that the region spanning ‑179 to +62 was the minimal promoter of IRF5. Bioinformatics analyses showed that this region contained three putative Sp1 binding sites, and mutational analyses revealed that all the Sp1 sites contributed to transcriptional activity. Secondly, the overexpression of Sp1 was found to increase the activity of the IRF5 promoter and the mRNA level of IRF5, determined using reporter gene assays and polymerase chain reaction analysis, respectively. By contrast, treatment with mithramycin and Sp1 small interfering RNA significantly reduced the activity of the IRF5 promoter and the mRNA level of IRF5. Finally, the results of an electrophoretic mobility shift assay and a chromatin immunoprecipitation assay demonstrated that Sp1 bound to the promoter region of IRF5 in vitro and in vivo. These results suggested that the Sp1 transcription factor is the primary determinant for activating the basal transcription of the IRF5.

View Figures

View References

1	Savitsky D, Tamura T, Yanai H and Taniguchi T: Regulation of immunity and oncogenesis by the IRF transcription factor family. Cancer Immunol Immunother. 59:489–510. 2010. View Article : Google Scholar : PubMed/NCBI
2	Takaoka A, Yanai H, Kondo S, Duncan G, Negishi H, Mizutani T, Kano S, Honda K, Ohba Y, Mak TW and Taniguchi T: Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature. 434:243–249. 2005. View Article : Google Scholar : PubMed/NCBI
3	Yanai H, Chen HM, Inuzuka T, Kondo S, Mak TW, Takaoka A, Honda K and Taniguchi T: Role of IFN regulatory factor 5 transcription factor in antiviral immunity and tumor suppression. Proc Natl Acad Sci USA. 104:3402–3407. 2007. View Article : Google Scholar : PubMed/NCBI
4	Krausgruber T, Saliba D, Ryzhakov G, Lanfrancotti A, Blazek K and Udalova IA: IRF5 is required for late-phase TNF secretion by human dendritic cells. Blood. 115:4421–4430. 2010. View Article : Google Scholar : PubMed/NCBI
5	Barnes BJ, Kellum MJ, Field AE and Pitha PM: Multiple regulatory domains of IRF-5 control activation, cellular localization, and induction of chemokines that mediate recruitment of T lymphocytes. Mol Cell Biol. 22:5721–5740. 2002. View Article : Google Scholar : PubMed/NCBI
6	Feng D, Stone RC, Eloranta ML, Sangster-Guity N, Nordmark G, Sigurdsson S, Wang C, Alm G, Syvänen AC, Rönnblom L and Barnes BJ: Genetic variants and disease-associated factors contribute to enhanced interferon regulatory factor 5 expression in blood cells of patients with systemic lupus erythematosus. Arthritis Rheum. 62:562–573. 2010.PubMed/NCBI
7	Kim K, Cho SK, Han TU, Kim JH, Kang SJ, Kang C and Bae SC: A redundant epistatic interaction between IRF5 and STAT4 of the type I interferon pathway in susceptibility to lupus and rheumatoid arthritis. Lupus. 22:1336–1340. 2013. View Article : Google Scholar : PubMed/NCBI
8	Lessard CJ, Li H, Adrianto I, Ice JA, Rasmussen A, Grundahl KM, Kelly JA, Dozmorov MG, Miceli-Richard C, Bowman S, et al: Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome. Nat Genet. 45:1284–1292. 2013. View Article : Google Scholar : PubMed/NCBI
9	Stone RC, Feng D, Deng J, Singh S, Yang L, Fitzgerald-Bocarsly P, Eloranta ML, Rönnblom L and Barnes BJ: Interferon regulatory factor 5 activation in monocytes of systemic lupus erythematosus patients is triggered by circulating autoantigens independent of type I interferons. Arthritis Rheum. 64:788–798. 2012. View Article : Google Scholar :
10	Barnes BJ, Kellum MJ, Pinder KE, Frisancho JA and Pitha PM: Interferon regulatory factor 5, a novel mediator of cell cycle arrest and cell death. Cancer Res. 63:6424–6431. 2003.PubMed/NCBI
11	Bi X, Feng D, Korczeniewska J, Alper N, Hu G and Barnes BJ: Deletion of Irf5 protects hematopoietic stem cells from DNA damage-induced apoptosis and suppresses γ-irradiation-induced thymic lymphomagenesis. Oncogene. 33:3288–3297. 2014. View Article : Google Scholar
12	Hu G and Barnes BJ: IRF-5 is a mediator of the death receptor-induced apoptotic signaling pathway. J Biol Chem. 284:2767–2777. 2009. View Article : Google Scholar
13	Massimino M, Consoli ML, Mesuraca M, Stagno F, Tirrò E, Stella S, Pennisi MS, Romano C, Buffa P, Bond HM, et al: IRF5 is a target of BCR-ABL kinase activity and reduces CML cell proliferation. Carcinogenesis. 35:1132–1143. 2014. View Article : Google Scholar : PubMed/NCBI
14	Yamashita M, Toyota M, Suzuki H, Nojima M, Yamamoto E, Kamimae S, Watanabe Y, Kai M, Akashi H, Maruyama R, et al: DNA methylation of interferon regulatory factors in gastric cancer and noncancerous gastric mucosae. Cancer Sci. 101:1708–1716. 2010. View Article : Google Scholar : PubMed/NCBI
15	Bi X, Hameed M, Mirani N, Pimenta EM, Anari J and Barnes BJ: Loss of interferon regulatory factor 5 (IRF5) expression in human ductal carcinoma correlates with disease stage and contributes to metastasis. Breast Cancer Res. 13:R1112011. View Article : Google Scholar : PubMed/NCBI
16	Massimino M, Vigneri P, Fallica M, Fidilio A, Aloisi A, Frasca F and Manzella L: IRF5 promotes the proliferation of human thyroid cancer cells. Mol Cancer. 11:212012. View Article : Google Scholar : PubMed/NCBI
17	Kreher S, Bouhlel MA, Cauchy P, Lamprecht B, Li S, Grau M, Hummel F, Köchert K, Anagnostopoulos I, Jöhrens K, et al: Mapping of transcription factor motifs in active chromatin identifies IRF5 as key regulator in classical Hodgkin lymphoma. Proc Natl Acad Sci USA. 111:E4513–E4522. 2014. View Article : Google Scholar : PubMed/NCBI
18	Mancl ME, Hu G, Sangster-Guity N, Olshalsky SL, Hoops K, Fitzgerald-Bocarsly P, Pitha PM, Pinder K and Barnes BJ: Two discrete promoters regulate the alternatively spliced human interferon regulatory factor-5 isoforms. Multiple isoforms with distinct cell type-specific expression, localization, regulation, and function. J Biol Chem. 280:21078–21090. 2005. View Article : Google Scholar : PubMed/NCBI
19	Graham RR, Kozyrev SV, Baechler EC, Reddy MV, Plenge RM, Bauer JW, Ortmann WA, Koeuth T, González Escribano MF; Argentine and Spanish Collaborative Groups; et al: A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet. 38:550–555. 2006. View Article : Google Scholar : PubMed/NCBI
20	Sigurdsson S, Göring HH, Kristjansdottir G, Milani L, Nordmark G, Sandling JK, Eloranta ML, Feng D, Sangster-Guity N, Gunnarsson I, et al: Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus. Hum Mol Genet. 17:872–881. 2008. View Article : Google Scholar
21	Briggs MR, Kadonaga JT, Bell SP and Tjian R: Purification and biochemical characterization of the promoter-specific transcription factor, Sp1. Science. 234:47–52. 1986. View Article : Google Scholar : PubMed/NCBI
22	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
23	Seznec J, Silkenstedt B and Naumann U: Therapeutic effects of the Sp1 inhibitor mithramycin A in glioblastoma. J Neurooncol. 101:365–377. 2011. View Article : Google Scholar
24	Xu HG, Jin R, Ren W, Zou L, Wang Y and Zhou GP: Transcription factors Sp1 and Sp3 regulate basal transcription of the human IRF-3 gene. Biochimie. 94:1390–1397. 2012. View Article : Google Scholar : PubMed/NCBI
25	Ren W, Zhu LH, Xu HG, Jin R and Zhou GP: Characterization of a spliced variant of human IRF-3 promoter and its regulation by the transcription factor Sp1. Mol Biol Rep. 39:6987–6993. 2012. View Article : Google Scholar : PubMed/NCBI
26	Clark DN, Read RD, Mayhew V, Petersen SC, Argueta LB, Stutz LA, Till RE, Bergsten SM, Robinson BS, Baumann DG, et al: Four promoters of IRF5 respond distinctly to stimuli and are affected by autoimmune-risk polymorphisms. Front Immunol. 4:3602013. View Article : Google Scholar : PubMed/NCBI
27	Kadonaga JT, Carner KR, Masiarz FR and Tjian R: Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain. Cell. 51:1079–1090. 1987. View Article : Google Scholar : PubMed/NCBI
28	Suske G: The Sp-family of transcription factors. Gene. 238:291–300. 1999. View Article : Google Scholar : PubMed/NCBI
29	Suske G, Bruford E and Philipsen S: Mammalian SP/KLF transcription factors: Bring in the family. Genomics. 85:551–556. 2005. View Article : Google Scholar : PubMed/NCBI
30	Philipsen S and Suske G: A tale of three fingers: The family of mammalian Sp/XKLF transcription factors. Nucleic Acids Res. 27:2991–3000. 1999. View Article : Google Scholar : PubMed/NCBI
31	Tan NY and Khachigian LM: Sp1 phosphorylation and its regulation of gene transcription. Mol Cell Biol. 29:2483–2488. 2009. View Article : Google Scholar : PubMed/NCBI